Major Adverse Cardiovascular Events: Risk Factors in Patients with RA Treated with Tofacitinib

被引：0
|
作者：
Charles-Schoeman, Christina [1 ]
Valdez, Hernan [2 ]
Soma, Koshika [2 ]
Hwang, Lie-Ju [2 ]
DeMasi, Ryan [2 ]
Boy, Mary [3 ]
McInnes, Iain B. [4 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Pfizer Inc, New York, NY USA
[3] Pfizer Inc, Groton, CT 06340 USA
[4] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3024
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Factors associated with adverse cardiovascular events in cancer patients treated with Bevacizumab
    Williams, Trent
    Ngo, Doan T. M.
    Horder, Sophie
    Kritharides, Leonard
    Vardy, Janette
    Mandaliya, Hiren
    Nordman, Ina I. C.
    Lynam, James
    Bonaventura, Tony
    Sverdlov, Aaron L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 21 - 21
  • [22] An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy
    Rao, Vijay U.
    Pavlov, Andrey
    Klearman, Micki
    Musselman, David
    Giles, Jon T.
    Bathon, Joan M.
    Sattar, Naveed
    Lee, Janet S.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (02) : 372 - 380
  • [23] CRP, Risk Factors and Major Adverse Cardiovascular Events: Insights From ACCELERATE
    Scherer, Daniel J.
    Nicholls, Stephen J.
    Lincoff, A. Michael
    Menon, Venu
    Riesmeyer, Jeffrey S.
    Ruotolo, Giacomo
    Weerakkody, Govinda J.
    Wolski, Kathy
    McErlean, Ellen
    Nissen, Steven E.
    CIRCULATION, 2017, 136
  • [24] Major Adverse Cardiovascular Events for Kidney Disease Patients Treated with Metformin or Sulfonylurea
    Roumie, Christianne
    Chipman, Jonathan J.
    Min, Jea Young
    Hung, Adriana M.
    Hackstadt, Amber J.
    Greevy, Robert A., Jr.
    Grijalva, Carlos G.
    Elasy, Tom
    Griffin, Marie R.
    DIABETES, 2019, 68
  • [25] IMPACT OF ANTIDEPRESSANTS ON RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH AND WITHOUT CARDIOVASCULAR DISEASE
    Lavoie, Kim L.
    Paine, Nicola J.
    Pelletier, Roxanne
    Arsenault, Andre
    Campbell, Tavis
    Pilote, Louise
    Bacon, Simon L.
    Diodati, Jean G.
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S1737 - S1738
  • [26] Analysis of Risk Factors for Major Adverse Cardiovascular Events in Patients with Coronary Stent Restenosis after Revascularization
    Yang, Zhuoxuan
    Wang, Tianjie
    Dong, Ying
    Liu, Long
    Xue, Xuan
    Wu, Jine
    Hao, Liuyi
    Yuan, Jiansong
    Cui, Jingang
    Qiao, Shubin
    Yang, Weixian
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (05)
  • [27] Major adverse limb events (MALE) and the relation with classical risk factors in patients with symptomatic cardiovascular disease
    Hageman, S. H. J.
    Dorresteijn, J. A. N.
    Bots, M. L.
    Westerink, J.
    Asselbergs, F. W.
    De Borst, G. J.
    Visseren, F. L. J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 845 - 845
  • [28] Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors
    Miao, Benjamin
    Hernandez, Adrian V.
    Alberts, Mark J.
    Mangiafico, Nicholas
    Roman, Yuani M.
    Coleman, Craig I.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (02):
  • [29] Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
    Fang-Ju Lin
    Wei-Kung Tseng
    Wei-Hsian Yin
    Hung-I Yeh
    Jaw-Wen Chen
    Chau-Chung Wu
    Scientific Reports, 7
  • [30] Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
    Lin, Fang-Ju
    Tseng, Wei-Kung
    Yin, Wei-Hsian
    Yeh, Hung-I
    Chen, Jaw-Wen
    Wu, Chau-Chung
    SCIENTIFIC REPORTS, 2017, 7
12345